Further follow-up, using long-term longitudinal studies of CP (cohort II) and AP patients that exhibited low levels of Gadd45a expression, will establish if Gadd45a expression is an early indicator of disease progression. This evidence concerns the gene GADD45A and alkaline phosphatase measurement.